Evidence map›Paper›PMID 25703566›Full record

ReviewImmunological reviews2015

Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma.

Molly A Matty, Francisco J Roca, Mark R Cronan, David M Tobin

Open access · greenAbstract readReview
In one paragraph

Review in Immunological reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. A granulin-positive macrophage subtype in mycobacterial granulomas alleviates tissue damage by limiting excessive inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A TNF-IL-1 circuit controlsbioRxiv : the preprint server for biology · 2023
    Article
  9. Article
  10. Article
  11. Immune Response and Apoptosis-Related Pathways Induced byPathogens (Basel, Switzerland) · 2021
    Article
  12. Review
  13. Lactate Metabolism and Signaling in Tuberculosis and Cancer: A Comparative Review.Frontiers in cellular and infection microbiology · 2021
    Review
  14. Comparison of hspX gene sequence in the Beijing and non-BeijingJournal of clinical tuberculosis and other mycobacterial diseases · 2020
    Article
  15. Article
  16. Article
  17. Review
  18. Convergence of non-communicable diseases and tuberculosis: a two-way street?The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Molly A MattyDepartment of Molecular Genetics and Microbiology, Center for Host-Microbial Interactions, Duke University Medical Center, Durham, NC, USA; University Program in Genetics and Genomics, Duke University, Durham, NC, USA.
Francisco J Roca
Mark R Cronan
David M Tobin
Duke University Hospital · USUniversity of Cambridge · GB

Funding

Modulating Eicosanoids to Treat Tuberculosis: Personalized, Host-directed TherapyDP2OD008614 · OD · DUKE UNIVERSITY · PI TOBIN, DAVID M. · 2011 to 2011
$2.4M
NIH HHS 1DP2-OD008614NIH HHS DP2 OD008614
6 · The paper itself

Abstract

Recent work in a variety of animal models, including mice, zebrafish, and macaques, as well as in humans, has led to a reassessment of several tenets of mycobacterial infection. In this review, we describe new findings about the composition and dynamics of the tuberculous granuloma, the central host structure in mycobacterial infection, as well as inflammatory mediators that drive a successful anti-microbial response on one hand and pathological inflammation on the other. We highlight granuloma heterogeneity that emerges in the context of infection, the functional consequences of angiogenesis in tuberculous granulomas, and data that balanced inflammation in humans, with a central role for tumor necrosis factor, appears to play a key role in optimal defense against mycobacterial infection. These findings have suggested new and specific host-directed therapies that await further clinical exploration.

Indexed as

Neovascularization, PathologicAnimalsAntitubercular AgentsCytokinesEicosanoidsGranulomaHumansHypoxiaInflammation MediatorsMycobacterium tuberculosisTuberculosisAntitubercular AgentsCytokinesEicosanoidsInflammation Mediatorsbacterial diseaseinflammationin vivo imagingmonocytes/macrophagestuberculosis

Identifiers

PMID25703566
PMCPMC4704445
OpenAlexW2018523876

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.